Name: AlectorLocation: San Francisco, as part of QB3 IncubatorWhat it Does: Developing immuno-modulatory therapies for Alzheimer’s disease, dementia and other neurodegenerative disorders.
December 8, 2015
1 Min Read
Name: Alector Location: San Francisco, as part of QB3 Incubator What it Does: Developing immuno-modulatory therapies for Alzheimer’s disease, dementia and other neurodegenerative disorders. GV Participation: New investor in $32 million Series C round. GV Investor: Blake Byers |
Sign up for the QMED & MD+DI Daily newsletter.
You May Also Like